Whereas a pathogenic role of E4 in frontotemporal dementia (FTD) is still a matter of debate [16], with a recent article pointing out an unexpectedly increased risk in carriers of the APOE‐E2 allele [17], inconsistent data are available for ALS [18]. This evidence concerns the gene APOE and frontotemporal dementia.